ESR1-mutant #breastcancers show increased mutational burden, proliferation, and enhanced mTORC1 signaling, linking ER activity to tumor aggressiveness. A multi-omic signature predicts #ESR1 mutations and identifies patients at higher risk of recurrence and poor outcomes.

doi.org/10.1038/s420...